Qvin
Diagnostic infrastructure for women's health.
A vertically integrated platform — collection, lab, software, regulatory — that turns menstrual blood into a recurring, non-invasive sample for screening, monitoring, and biomarker discovery across gynecologic and systemic disease.
Proof points
Regulated, validated, and shipping at scale.
- FDA · CE · UKCA first diagnostic menstrual blood collection device cleared in three jurisdictions [1]
- r > 0.9 correlation with venous blood across HbA1c, TSH, AMH and more [2]
- Peer-reviewed published validation across A1c, hormones, HPV, and broader biomarkers [2]
- Stanford · Mayo · Exeter · SSI institutional research collaborations active today
The opportunity
Menstrual blood is the most accessible clinical sample women have ever had.
Over 70% of medical decisions today are driven by lab work. Menstrual blood is biologically rich — endometrial cells, immune components, hormones, and protein biomarkers reflective of both gynecologic and systemic health — and uniquely recurring. The Q-Pad, Qvin's FDA-cleared diagnostic menstrual pad, captures Dried Menstrual Samples (DMS) passively, monthly, at home. The result is a regulated, scalable substrate that supports molecular, chemistry, protein, and multi-omics workflows.
Where to start
Explore the platform.
Collection
The Q-Pad and the cup as a research kit. How the sample gets from home to lab.
Science
Why menstrual blood works. Peer-reviewed validation. The DMS analytical surface.
Conditions
Cervical cancer, endometriosis, menopause, HMB, fertility, and more.
Commercial
How to partner with Qvin — academic, industry, philanthropic, investor.
In the press
Selected coverage.
Full coverage on Media.
References
Sources
- U.S. Food & Drug Administration. 510(k) Premarket Notification database — Q-Pad cleared device record. accessdata.fda.gov.
- Naseri S, Rosenberg-Hasson Y, Maecker HT, Avrutsky MI, Park CL. Demonstration of menstrual blood as a viable source for screening and diagnostic clinical applications: a pilot study. BMC Women's Health, 2023. bmcwomenshealth.biomedcentral.com.